Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

0
Player Avatar mdmardim (< 20) Submitted: 3/4/2010 8:59:18 PM : Outperform Start Price: $21.62 BRLI Score: -22.26

People are always having tests done so a company like this is a cash cow. It could be a takeover candidate for Quest or maybe Mr. Buffet may feel warm blooded and buy this body fluid testing company.

Featured Broker Partners


Advertisement